A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

PHASE2TerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

July 27, 2018

Study Completion Date

July 27, 2018

Conditions
Motor Neuron Disease
Interventions
DRUG

FLX-787-ODT (orally disintegrating tablet)

FLX-787-ODT taken three times daily for 28 days

DRUG

Placebo ODT

Placebo ODT taken three times daily for 28 days

Trial Locations (35)

10021

Hospital for Special Surgery, New York

15213

University of Pittsburgh, Pittsburgh

17033

Penn State Milton S. Hershey Medical Center, Hershey

19140

Temple University, Philadelphia

20037

GW Medical Faculty Associates Inc., Washington D.C.

21205

Johns Hopkins Hospital, Baltimore

23298

Virginia Commonwealth University, Richmond

27157

Wake Forest University, Winston-Salem

27405

Guilford Neurologic Associates, Greensboro

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

32224

Mayo Clinic, Jacksonville

33612

University of South Florida Health, Tampa

46202

Indiana University Neuroscience Center, Indianapolis

52242

University of Iowa Hospitals and Clinics, Iowa City

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

63104

Saint Louis University, St Louis

66160

University of Kansas Medical Center, Kansas City

78229

UT Health San Antonio, San Antonio

78665

Baylor Scott and White Health, Round Rock

78756

Austin Neuromuscular Center, Austin

80045

University of Colorado, Aurora

84112

The University of Utah, Salt Lake City

85251

Honor Health Research Institute, Scottsdale

85259

Mayo Clinic, Scottsdale

94115

California Pacific Medical Center, Sacramento

94143

University of California San Francisco, San Francisco

95817

University of California - Davis, Sacramento

97213

Providence Brain and Spine Institute, Portland

97239

Oregon Health Sciences University, Portland

99202

Saint Luke's Rehabilitation Institute, Spokane

06053

Hospital for Special Care, New Britain

01805

Lahey Hospital and Medical Center, Burlington

05405

University of Vermont Medical Center, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Flex Pharma, Inc.

INDUSTRY